1. |
Zhang G, Chen H, Chen W, et al. Prevalence andrisk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study[J]. Br J Ophthalmol, 2017, 101(12): 1591-1595. DOI: 10.1136/bjophthalmol-2017-310316.
|
2. |
邓宇轩, 叶雯青, 孙艳婷, 等. 中国糖尿病视网膜病变患病率的荟萃分析[J]. 中华医学杂志, 2020, 100(48): 3846-3852. DOI: 10.3760/cma.j.cn112137-20200925-02720.Deng YX, Ye WQ, Sun YT, et al. A meta-analysis of prevalence of diabetic retinopathy in China[J]. Natl Med J China, 2020, 100(48): 3846-3852. DOI: 10.3760/cma.j.cn112137-20200925-02720.
|
3. |
Tang FY, Chan EO, Sun Z, et al. Clinically relevant factors associated with quantitative optical coherence tomography angiography metrics in deep capillary plexus in patients with diabetes[J]. Eye Vis (Lond), 2020, 7(1): 7. DOI: 10.1186/s40662-019-0173-y.
|
4. |
黄海燕, 李德爽, 谷浩, 等. OCT和OCTA生物学标志物在糖尿病性黄斑水肿预后和监测中的应用[J]. 国际眼科杂志, 2024, 24(5): 743-748. DOI: 10.3980/j.issn.1672-5123.2024.5.15.Huang HY, Li DS, Gu H, et al. Application of optical coherence tomography and optical coherence tomography angiography biomarkers in the prognosis and monitoring of diabetic macular edema[J]. Int Eye Sci, 2024, 24(5): 743-748. DOI: 10.3980/j.issn.1672-5123.2024.5.15.
|
5. |
陶勇. 眼内液病原学检测的研究进展[J]. 中华眼科杂志, 2018, 54(7): 551-556. DOI: 10.3760/cma.j.issn.0412-4081.2018.07.019.Tao Y. Research on examination of intraocular fluid for diagnosis of infectious ocular diseases[J]. Chin J Ophthalmol, 2018, 54(7): 551-556. DOI: 10.3760/cma.j.issn.0412-4081.2018.07.019.
|
6. |
许畅, 毛晓春. 正常人黄斑中央凹无血管区域面积分析[J]. 国际眼科杂志, 2017, 17(3): 499-503. DOI: 10.3980/j.issn.1672-5123.2017.3.28.Xu C, Mao XC. Foveal avascular zone area in normal subjects[J]. Int Eye Sci, 2017, 17(3): 499-503. DOI: 10.3980/j.issn.1672-5123.2017.3.28.
|
7. |
Yokoyama T, Maruko I, Koizumi H, et al. Unmeasurable small size of foveal avascular zone without visual impairment in optical coherence tomography angiography[J]. Eye (Lond), 2018, 32(6): 1062-1066. DOI: 10.1038/s41433-017-0005-z.
|
8. |
Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography[J]. Retina, 2015, 35(11): 2377-2383. DOI: 10.1097/IAE.0000000000000849.
|
9. |
Sorour OA, Sabrosa AS, Alibhai AY, et al. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy[J]. Int Ophthalmol, 2019, 39(10): 2361-2371. DOI: 10.1007/s10792-019-01076-x.
|
10. |
Wu H, Hwang DK, Song X, et al. Association between aqueous cytokines and diabetic retinopathy stage[J/OL]. J Ophthalmol, 2017, 2017: 9402198[2017-06-07]. https://pubmed.ncbi.nlm.nih.gov/28680705/. DOI: 10.1155/2017/9402198.
|
11. |
Feng S, Yu H, Yu Y, et al. Levels of inflammatory cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in aqueous humour of patients with diabetic retinopathy[J/OL]. J Diabetes Res, 2018, 2018: 8546423[2018-04-04]. https://pubmed.ncbi.nlm.nih.gov/29850610/. DOI: 10.1155/2018/8546423.
|
12. |
Wu J, Zhong Y, Yue S, et al. Aqueous humor mediator and cytokine aberrations in diabetic retinopathy and diabetic macular edema: a systematic review and meta-analysis[J/OL]. Dis Markers, 2019, 2019: 6928524[2019-11-23]. https://pubmed.ncbi.nlm.nih.gov/31871502/. DOI: 10.1155/2019/6928524.
|
13. |
Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease[J]. Genome Biol, 2005, 6(2): 209. DOI: 10.1186/gb-2005-6-2-209.
|
14. |
Tamhane M, Cabrera-Ghayouri S, Abelian G, et al. Review of biomarkers in ocular matrices: challenges and opportunities[J]. Pharm Res, 2019, 36(3): 40. DOI: 10.1007/s11095-019-2569-8.
|
15. |
Oh IK, Kim SW, Oh J, et al. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy[J]. Curr Eye Res, 2010, 35(12): 1116-1127. DOI: 10.3109/02713683.2010.510257.
|